INTENDED FOR UK AND IRELAND HEALTHCARE PROFESSIONALS HomePrescribing information

 

RESPIRATORY ADVERSE REACTIONS WITH BRONCHITOL DURING THE PHASE 3 STUDIES

aAdverse reactions that occurred only with the initiation dose assessment (MTT)

 

For the full list of Adverse Events, please see the UK Summary of Product Characteristics or the Ireland Summary of Product Characteristics.

A productive cough can contribute to sputum clearance.1

Following bronchodilator use and initiation dose assessment, the incidence of bronchospasm is low2,3